Psychological Impact of Melanoma, How to Detect, Support and Help.
Anxiety
Depression
Melanoma
Psychology
Journal
Open access Macedonian journal of medical sciences
ISSN: 1857-9655
Titre abrégé: Open Access Maced J Med Sci
Pays: North Macedonia
ID NLM: 101662294
Informations de publication
Date de publication:
30 Sep 2019
30 Sep 2019
Historique:
received:
13
06
2019
revised:
04
07
2019
accepted:
05
07
2019
entrez:
19
12
2019
pubmed:
19
12
2019
medline:
19
12
2019
Statut:
epublish
Résumé
Incidence of melanoma is increasing every year. A few years ago, we could not speak about long term survivors with melanoma. Chemotherapy did not give a good effect in the past. Metastasis occurred very rapidly, and the progression of melanoma was very fast. But now, with new forms of therapy, especially immunotherapy and target therapy, for the first time, we have long-time survivors. For the prognosis of melanoma, the most important is the stage in which melanoma is detected. For all dermatologists, it is very important to be aware of the psychological impact of melanoma on patients. Dermatologists should recognise psychological disorders. Several different scales can be used for the detection of depression and anxiety - some of them are completed by researchers, some of them are completed by patients, and also, we have combined scales. The need for adequate social and family support as well as psychological help to achieve better coping with illness is necessary. Learning techniques to overcome fear and stress would help in better functioning of all affected, regardless of the stage of the disease. The most severe cases of anxiety and depression, in addition to psychotherapeutic interventions, should also be considered medication therapy.
Identifiants
pubmed: 31850119
doi: 10.3889/oamjms.2019.770
pii: OAMJMS-7-3043
pmc: PMC6910785
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
3043-3045Informations de copyright
Copyright: © 2019 Aleksandra Vojvodic, Tatjana Vlaskovic-Jovicevic, Petar Vojvodic, Jovana Vojvodic, Mohamad Goldust, Zorica Peric-Hajzler, Dusica Matovic, Goran Sijan, Nenad Stepic, Van Thuong Nguyen, Michael Tirant, Uwe Wollina, Torello Lotti, Massimo Fioranelli.
Références
J Clin Oncol. 2016 Dec 20;34(36):4405-4414
pubmed: 27998215
Dermatol Ther. 2012 Sep-Oct;25(5):458-62
pubmed: 23046025
G Ital Dermatol Venereol. 2019 Jun 12;:null
pubmed: 31195781
Nature. 2014 Nov 13;515(7526):181
pubmed: 25391942
Arch Intern Med. 2011 Apr 25;171(8):779-81
pubmed: 21518948
Support Care Cancer. 2019 May 14;:null
pubmed: 31089820
Anticancer Res. 2019 May;39(5):2633-2640
pubmed: 31092462
Dermatol Ther. 2017 Nov;30(6):
pubmed: 28836714
Dermatol Ther. 2015 Nov-Dec;28(6):344-5
pubmed: 26279288
J Oncol. 2019 Apr 28;2019:5269062
pubmed: 31182961
J Biol Regul Homeost Agents. 2017 Jul 13;31(2 Suppl. 2):53-55
pubmed: 28702965
J Oncol. 2018 Mar 20;2018:5253109
pubmed: 29755525
Expert Rev Anticancer Ther. 2011 May;11(5):739-47
pubmed: 21554049
Psychooncology. 2018 Jul;27(7):1727-1734
pubmed: 29601654
Asian Pac J Cancer Prev. ;18(2):369-373
pubmed: 28345333